Tuesday, June 10, 2014

Review of washington dc injury lawyer::Can You Be a Teacher in Washington State If You Have a ...







Review of washington dc injury lawyer::Can You Be a Teacher in Washington State If You Have a ...








Since               the               first               SSRI               antidepressant               was               released               in               1988,               over               200               lawsuits               have               been               brought               against               the               major               SSRI               makers,               including               AstraZeneca,               Pfizer,               GlaxoSmithKline,               and               Eli               Lilly.

For               the               most               part               the               lawsuits               have               been               in               response               to               episodes               of               aggressive               behavior               including               suicide               and               homicide               attempts               caused               by               SSRIs               side               effects.

Seroquel               (Quetiapine)
               Seroquel's               blood               sugar,               weight               gain,               and               heart               side               effects               are               well-known.

AstraZeneca,               maker               of               Seroquel,               engaged               in               deceptive               and               misleading               practices               when               it               marketed               Seroquel               for               unauthorized,               or               "off-label,"               uses               and               failed               to               adequately               disclose               the               drug's               serious               potential               side               effects               to               health               care               providers,               including               hyperglycemia               and               diabetes               mellitus.

Its               2009               approval               as               a               drug               for               depression               helped               it               reach               sales               of               $5.3               billion,               and               it               was               also               approved               for               schizophrenia               and               bipolar               disorder.

FDA               regulators               opposed               its               use               as               a               first-choice,               stand-alone               treatment               for               the               10               percent               of               the               U.S.

population               with               depression               when               safer               treatments               exist.
               The               Illinois               state               Attorney               General's               office               has               reached               a               $3.1               million               settlement               with               the               major               pharmaceutical               company               AstraZeneca               following               allegations               that               it               improperly               marketed               and               promoted               Seroquel.

The               agreement               is               part               of               a               record               37-state               settlement               totaling               $68.5               million,               the               largest               ever               multi-state               consumer               protection               settlement               against               pharmaceutical               companies.

These               practices               violate               Informed               Consent               requirements               set               forth               by               federal               law               to               protect               patients               and               ensure               that               health               care               providers               are               fully               informed               about               the               medications               they               prescribe,               including               all               known               potential               benefits               and               side               effects.

AstraZeneca               has               already               settled               nearly               25,000               personal-injury               lawsuits               pertaining               to               Seroquel,               with               more               to               come,               says               ABC               News.
               Prozac               (Fluoxetine               HCL)
               Eli               Lilly's               Prozac               was               the               first               SSRI               on               the               market               in               1988.

According               to               Lilly's               Prozac               website,               Prozac               has               been               prescribed               for               more               than               40               million               people               worldwide.

In               recent               years,               Prozac               has               also               become               available               in               its               generic               form,               Fluoxetine               HCL.
               The               question               of               whether               or               not               Prozac               can               cause               some               people               to               become               homicidal               or               suicidal               goes               back               many               years.

In               February               1990,               two               prominent               Harvard               researchers               and               psychiatrists,               Dr.

Martin               Teicher               and               Dr.

Jonathan               Cole               published               an               article               in               the               American               Journal               of               Psychiatry               entitled:               Emergence               of               Intense               Suicidal               Preoccupation               During               Fluoxetine               Treatment.

The               article               reported               that               "persistent,               obsessive,               and               violent               suicidal               thoughts               emerged               in               a               small               minority               of               patients               treated               with               fluoxetine."               Since               that               time,               many               other               researchers               have               published               articles               with               similar               findings.

However,               those               articles               have               been               largely               ignored               by               the               popular               media               and               dismissed               by               the               pharmaceutical               industry               and               the               FDA.
               In               the               meantime,               various               lawyers               have               amassed               considerable               damning               evidence               from               the               internal,               unpublished               files               of               Eli               Lilly.
               Although               no               civil               wrongful               death               case               has               yet               been               won,               Lilly               has               lost               many               battles               on               the               issue               of               whether               there               is               legally               admissible,               scientifically               reliable               evidence               linking               Prozac               to               suicide               and               other               violent               behavior.
               Most               of               the               civil               cases               involving               Prozac               have               been               settled               out               of               court.

However,               in               the               two               cases               which               have               gone               to               trial,               Lilly               has               achieved               "apparent"               wins.

The               first               was               a               1994               case               in               Kentucky               state               court.

Lilly               got               a               9:3               verdict               in               its               favor               and               then               publicized               this               verdict               as               a               "vindication"               of               Prozac.

It               was               later               found               that               Lilly               had               quietly               settled               the               case               for               an               undisclosed               sum               before               the               verdict               was               returned.
               On               March               22,               2004,               the               question               "Can               Prozac               cause               suicide               in               some               people?"               was               finally               answered.

Prozac               was               named               in               the               FDA               Public               Health               Advisory               warning               of               a               link               between               antidepressants               and               suicide.

The               advisory               states,               "health               care               providers               should               carefully               monitor               patients               receiving               antidepressants               for               possible               worsening               of               depression               or               suicidality,               especially               at               the               beginning               of               therapy               or               when               the               dose               either               increases               or               decreases."
               Paxil               (Paroxetine               HCl)
               "Can               Paxil               cause               some               people               to               become               homicidal               and/or               suicidal?"               This               was               the               first               question               posed               to               the               jury               in               the               case               of               Tobin               v.

SmithKline               Beecham.

Their               June               6,               2001,               verdict               answered               with               a               resounding               "yes"               and               an               $8               million               damage               assessment.
               Paxil,               which               was               released               onto               the               American               market               in               1992,               was               the               third               of               the               SSRI's               on               the               market               in               the               US.

Paxil               is               FDA               approved               for               the               treatment               of               depression               and               certain               anxiety               disorders.

Paxil               and               the               new               Paxil               CR               (controlled               release)               generate               over               two               billion               dollars               per               year               for               GlaxoSmithKline               making               it               one               of               the               company's               biggest               sellers.
               On               March               22,               2004,               Paxil               was               included               in               the               FDA               Public               Health               Advisory               finally               acknowledging               the               link               between               antidepressants               and               suicide.

The               advisory               states               "health               care               providers               should               carefully               monitor               patients               receiving               antidepressants               for               possible               worsening               of               depression               or               suicidality,               especially               at               the               beginning               of               therapy               or               when               the               dose               either               increases               or               decreases."
               For               the               first               time,               a               jury               found               a               pharmaceutical               firm               liable               for               the               death               of               a               patient               taking               an               antidepressant.

A               federal               jury               in               Cheyenne,               Wyoming,               ordered               SmithKline               Beecham               (now               GlaxoSmithKline)               to               pay               $6.4               million               to               relatives               of               Donald               Schell.

Schell,               age               60,               had               been               taking               Paxil               for               just               48               hours               when               he               shot               and               killed               his               wife,               his               daughter,               his               granddaughter               and               himself.

The               verdict               may               alter               the               landscape               in               a               class               action               suit               that               has               floundered               in               the               courts.
               Although               plaintiffs'               lawyers               had               filed               hundreds               of               cases               against               the               manufacturers               of               the               three               leading               antidepressants,               all               but               three               of               those               suits               were               dismissed               or               settled.

The               first               two               cases               to               reach               trial,               both               against               the               makers               of               Prozac,               ended               in               verdicts               for               the               manufacturer.

But               now,               with               the               dramatic               victory               in               the               Paxil               case,               plaintiffs'               lawyers               say               the               drug               companies               will               be               more               willing               to               settle               and               will               face               a               tougher               future               when               they               take               cases               to               court.

According               to               Andy               Vickery,               who               tried               the               case               for               the               plaintiffs,               the               verdict               lays               firm               groundwork               for               future               cases               involving               Paxil               because               the               Wyoming               jury               found               the               medication               could               cause               someone               to               commit               suicide               or               homicide.

He               also               believes               the               verdict               is               bad               news               for               makers               of               the               other               two               antidepressants               which               will               be               implicated               by               association.
               Zoloft               (Sertraline)
               Zoloft               is               an               antidepressant               that               has               has               been               linked               to               suicidal               behavior               in               some               users.

Zoloft               is               used               to               treat               depression,               panic               disorder,               social               anxiety               disorder,               obsessive               compulsive               disorder,               premenstrual               dysphoric               disorder,               and               post-traumatic               stress               disorder               in               adults,               children               and               adolescents.

It               is               manufactured               by               the               drug               maker               Pfizer.
               In               December               of               2001,               Flora               Motus               of               California               sued               Pfizer               for               selling               a               drug               that               drove               her               husband               Victor               Motus               to               suicide.

In               1998,               Victor               Motus               was               scheduled               to               fly               to               Washington               DC               to               receive               an               award               from               President               Clinton               for               his               work               in               a               local               school               district,               when               instead,               he               killed               himself.

He               had               stated               on               multiple               occasions               previously               that               the               Zoloft               he               was               using               was               making               him               "crazy."               Motus's               lawyers               argued               that               Pfizer               should               include               a               warning               that               Zoloft               could               cause               suicide               thoughts               in               some               people.
               Pfizer's               legal               team               was               aware               of               Tobin               v.

SmithKline               trial               and               fearing               that               their               case               might               face               the               same               outcome               sought               help               from               Daniel               E.

Troy,               Chief               Legal               Counsel               of               the               US               Food               and               Drug               Administration.

Immediately               prior               to               his               appointment               of               Chief               Legal               Counsel,               he               had               been               a               Pfizer               lawyer               and               long-time               champion               of               the               drug               companies,               working               against               the               federal               agency               he               now               worked               for.
               The               Pfizer               legal               team               asked               Troy               to               file               a               brief               saying               that               the               FDA               agreed               with               Pfizer's               contention               that               SSRIs               do               not               increase               the               likelihood               of               suicidal               behavior.

Troy               completely               ignored               the               current               findings               and               filed               a               brief               that               stated               that               the               FDA               had               dismissed               the               idea               that               SSRI               antidepressants               increase               some               people's               risk               of               suicide.

When               later               asked               about               the               recently               concluded               Tobin               case,               Troy               claimed               that               he               was               unfamiliar               with               it.
               Lexapro               (Escitalopram)
               Developed               by               the               Danish               pharmaceutical               company               Lundbeck,               Escitalopram               was               introduced               to               the               U.S.

market               under               the               name               Lexapro               and               distributed               by               the               American               pharmaceutical               company               Forest               in               2002.

The               antidepressant               Lexapro               is               used               to               treat               major               depression,               some               associated               with               mood               disorders.
               Since               its               introduction,               Lexapro               has               come               under               close               scrutiny               for               its               connection               to               suicide               in               children,               adolescents,               and               adults.

Lexapro               and               Celexa               have               been               included               in               the               recent               FDA               Public               Health               Advisories               on               antidepressants               and               suicide.

The               FDA               has               required               the               manufacturer,               Forest               Laboratories,               to               include               a               Black               Box               warning               about               the               increased               risk               of               suicide               in               children               and               adolescents               taking               Lexapro               or               Celexa.
               Celexa               (Citalopram               HBr)               and               Lexapro               (Escitalopram               Oxalate)               are               members               of               the               class               of               drugs               known               as               SSRIs               (Selective               Serotonin               Reuptake               Inhibitors)               which               also               include               Prozac,               Paxil               and               Zoloft.

Forest               Pharmaceuticals               received               FDA               approval               for               Celexa               in               1998.

Celexa               was               touted               as               having               fewer               side               effects               than               earlier               SSRI               drugs.
               Effexor               (Venlafaxine               HCL)
               Effexor               (Venlafaxine               HCL)               was               introduced               in               1993               by               Wyeth               Pharmaceuticals.

It               belongs               to               a               class               of               drugs               called               SNRI.

Wyeth's               Effexor               XR               website               states,               "Effexor               XR               is               thought               to               work               on               both               serotonin               and               norepinephrine               -               two               chemicals               in               the               brain               linked               to               depression.

Correcting               the               imbalance               of               these               two               chemicals               may               help               relieve               symptoms               of               depression
               In               August               of               2003,               Wyeth               warned               physicians               about               about               the               link               between               Effexor               and               increased               incidence               of               hostility               and               suicide-related               events,               such               as               suicidal               thoughts               and               self-harm.

Doctors               were               warned               to               be               alert               to               signs               of               suicidal               ideation               in               children               and               adolescents               using               Effexor               or               Effexor               XR               and               to               reassess               the               benefit-risk               ratio               when               treating               individual               patients.
               Since               that               time,               the               FDA               has               acknowledged               the               link               between               Effexor               and               suicide               issuing               several               public               health               advisories               and               requiring               Wyeth               to               put               a               Black               Box               Warning               on               Effexor.

An               FDA               public               health               advisory               stated:
               "Adults               being               treated               with               antidepressant               medications,               particularly               those               being               treated               for               depression,               should               be               watched               closely               for               worsening               of               depression               and               for               increased               suicidal               thinking               or               behavior.

Close               watching               may               be               especially               important               early               in               treatment,               or               when               the               dose               is               changed,               either               increased               or               decreased."
               Cymbalta               (Duloxetine)
               Cymbalta               (Duloxetine               HCl),               manufactured               by               Eli               Lilly,               was               approved               by               the               FDA               and               approved               for               sale               in               August               of               2004.

Labeling               for               Cymbalta               warns               about               the               increased               risk               of               suicide.
               Traci               Johnson,               a               19-year-old               woman,               with               no               previous               depressive               symptoms,               was               participating               in               a               clinical               trial               for               Cymbalta               when               she               committed               suicide               on               the               7th               of               February               2004,               by               hanging               herself               in               the               Lilly               Laboratory               for               Clinical               Research.

In               previous               trials               of               Cymbalta,               there               were               four               other               individuals               who               had               committed               suicide,               and               eleven               had               attempted               suicide.

Traci               Johnson               had               joined               the               trial               only               a               few               weeks               earlier,               in               January.
               You               are               entitled               to               Informed               Consent,               under               the               Patient's               Bill               of               Rights,               a               bill               first               adopted               by               the               American               Hospital               Association               in               1973.

The               bill               states               that               you               have               the               right               to               considerate               and               respectful               care,               and               you               are               encouraged               to               obtain               from               physicians               and               other               direct               caregivers               relevant,               current,               and               understandable               information               concerning               diagnosis,               treatment,               and               prognosis.

In               keeping               with               these               practices,               I               have               informed               you               of               the               Top               7               Dangerous               Psychiatric               Drugs,               and               I               strongly               recommend               that               you               thoroughly               investigate               any               drug               prescribed               to               you               by               any               doctor,               especially               psychiatrists.

To               protect               yourself,               investigate               any               drugs               recommended               or               prescribed               to               you               on               reputable               websites               not               related               to               pharmaceutical               companies,               and               go               BlackBoxRX.com               for               an               extensive               list               of               all               medications               with               Black               Box               warnings.

Be               an               informed               consumer,               not               a               guinea               pig.

Be               healthy,               be               happy,               and               take               care               of               yourself.
               Michael               Locklear               is               a               researcher               and               consultant               with               30               years               experience,               studying               health,               nutrition,               and               human               behavior.

He               has               been               president               of               the               Global               Peace               Project               since               1986,               and               he               administrates               the               website               www.Natural-Remedies-for-Total-Health.com               as               part               of               the               Global               Peace               Project               Educational               Outreach               Program.

You               can               also               find               him               on               The               Total               Health               Blog.






Image of washington dc injury lawyer






washington dc injury lawyer
washington dc injury lawyer


washington dc injury lawyer Image 1


washington dc injury lawyer
washington dc injury lawyer


washington dc injury lawyer Image 2


washington dc injury lawyer
washington dc injury lawyer


washington dc injury lawyer Image 3


washington dc injury lawyer
washington dc injury lawyer


washington dc injury lawyer Image 4


washington dc injury lawyer
washington dc injury lawyer


washington dc injury lawyer Image 5


  • Related blog with washington dc injury lawyer








  • Related Video with washington dc injury lawyer







    washington dc injury lawyer Video 1








    washington dc injury lawyer Video 2








    washington dc injury lawyer Video 3




    washington dc injury lawyer





























    Labels: , , , , , , ,